Grifols s.r.o. operates as the Czech-market subsidiary of Grifols, a global healthcare company with core activities spanning biopharma and diagnostics. Established in the Czech Republic in 1992 and based in Prague, the company covers both the Czech and Slovak markets, providing a portfolio of Grifols products and services to healthcare customers. Business scope includes plasma-derived medicines and related biopharmaceutical solutions, supported by offerings in transfusion medicine and diagnostic technologies, aligning to hospital and laboratory needs across the donation-to-transfusion continuum as well as broader clinical diagnostics. Geographic reach combines local commercial coverage across two national markets with integration into a global platform that develops and supplies therapies and diagnostics internationally. Key assets include Grifols brand and portfolio access, local commercial and distribution presence, and technical support interfaces for healthcare customers. Strategic focus is on safety and quality in healthcare supply, strengthening market coverage in Czech and Slovak territories, and delivering mission-driven health outcomes through innovative therapies and diagnostics supported by global R&D and quality systems.
Headquarters
Rohanske nabrezi 670/17
Prague; The City of Prague;
Postal Code: 18600
Contact Details: Purchase the Grifols S.R.O. report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service